X4 Pharmaceuticals Inc [NASDAQ: XFOR] traded at a low on Tuesday, posting a -9.17 loss after which it closed the day’ session at $1.09.
The results of the trading session contributed to over 4732407 shares changing hands. Over the past one week, the price volatility of X4 Pharmaceuticals Inc stands at 7.99% while the volatility over the past one month is 12.58%.
The market cap for XFOR stock reached $183.05 million, with 167.43 million shares outstanding and 122.08 million shares in the current float. Compared to the average trading volume of 3.16M shares, XFOR reached a trading volume of 4732407 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about X4 Pharmaceuticals Inc [XFOR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XFOR shares is $4.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XFOR stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
B. Riley Securities have made an estimate for X4 Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 12, 2023. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on August 30, 2023, representing the official price target for X4 Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on XFOR stock.
The Average True Range (ATR) for X4 Pharmaceuticals Inc is set at 0.14 The Price to Book ratio for the last quarter was 3.57, with the Price to Cash per share for the same quarter was set at 0.68.
How has XFOR stock performed recently?
X4 Pharmaceuticals Inc [XFOR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.68. With this latest performance, XFOR shares dropped by -15.50% in over the last four-week period, additionally plugging by 15.26% over the last 6 months – not to mention a drop of -35.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XFOR stock in for the last two-week period is set at 44.29, with the RSI for the last a single of trading hit 41.72, and the three-weeks RSI is set at 46.60 for X4 Pharmaceuticals Inc [XFOR]. The present Moving Average for the last 50 days of trading for this stock 1.1613, while it was recorded at 1.1250 for the last single week of trading, and 1.0337 for the last 200 days.
X4 Pharmaceuticals Inc [XFOR]: Deeper insight into the fundamentals
X4 Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.34 and a Current Ratio set at 5.34.
Insider trade positions for X4 Pharmaceuticals Inc [XFOR]
The top three institutional holders of XFOR stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in XFOR stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in XFOR stock with ownership which is approximately 5.8386%.
